GenesisCare makes major investment in Elekta cancer treatment equipment as it enters U.S. market
Elekta closes major order of around USD 200 million, including numerous linacs, service agreements and 11 Elekta Unity systems, surpassing the target of 75ATLANTA, May 18, 2020 – Elekta (EKTA-B.ST) announced today that Australian-headquartered cancer care provider GenesisCare has ordered several Elekta linear accelerators (linacs) – of which 11 are Elekta Unity MR-Linac systems – to ensure that U.S. cancer clinics have the latest treatment solutions available. The total order value is around USD 200 million (approx. SEK 2 billion) over the next five years. The order value booked during the